In addition, the joint statement of European Respiratory Society and the American Thoracic Society on serum lung cancer did not include CEA or any other markers for diagnosis, screening, staging or monitoring the effects of cancer treatment[14]. This evidence concerns the gene CEACAM5 and lung carcinoma.